Dynamic Contrast-enhanced T2*-weighted MR Imaging of Tumefactive Demyelinating Lesions

References

1. ↵
   Zagzag D, Miller DC, Kleinman GM, Abati A, Donnenfeld H, Budzilovich GN. Demyelinating disease versus tumor in surgical neuropathology: clues to a correct pathological diagnosis. Am J Surg Pathol 1993;17:537-545

   CrossRefPubMedWeb of Science
2. ↵
   Hunter SB, Ballinger WE Jr, Rubin JJ. Multiple sclerosis mimicking primary brain tumor. Arch Pathol Lab Med 1987;111:464-468

   PubMedWeb of Science
3. Giang DW, Poduri KR, Eskin TA, et al. Multiple sclerosis masquerading as a mass lesion. Neuroradiology 1992;34:150-154

   CrossRefPubMedWeb of Science
4. ↵
   Prineas JW, McDonald WI. Demyelinating diseases. Greenfield's Neuropathology. ed 6. vol I. New York: Wiley; 1997:814–846
5. ↵
   Kepes JJ. Large focal tumor-like demyelinating lesions of the brain: intermediate entity between multiple sclerosis and acute disseminated encephalomyelitis? a study of 31 patients. Ann Neurol 1993;33:18-27

   CrossRefPubMedWeb of Science
6. ↵
   Nesbit GM, Forbes GS, Scheithauer BW, Okazaki H, Rodriguez M. Multiple sclerosis: histopathologic and MR and/or CT correlation in 37 cases at biopsy and three cases at autopsy. Radiology 1991;180:467-474

   PubMedWeb of Science
7. Kurihara N, Takahashi S, Furuta A, et al. MR imaging of multiple sclerosis simulating brain tumor. Clin Imaging 1996;20:171-177

   CrossRefPubMedWeb of Science
8. ↵
   Burger PC, Vogel FS. The brain: tumors. In: Burger PC, Vogel FS, eds. Surgical Pathology of the Central Nervous System and Its Coverings. New York: Wiley; 1982:223–266
9. Burger PC, Vogel FS, Green SB, Strike TA. Glioblastoma multiforme and anaplastic astrocytoma: pathologic criteria and prognostic implications. Cancer 1985;56:1106-1111

   CrossRefPubMedWeb of Science
10. Burger P. Malignant astrocytic neoplasms: classification, pathology, anatomy, and response to therapy. Semin Oncol 1986;13:16-20

    PubMed
11. ↵
    Daumas-Duport C, Scheithauer B, O'Fallon J, Kelly P. Grading of astrocytomas: a simple and reproducible method. Cancer 1988;62:2152-2165

    CrossRefPubMedWeb of Science
12. ↵
    Knopp EA, Cha S, Johnson G, et al. Glial neoplasms: dynamic contrast-enhanced T2*-weighted MR imaging. Radiology 1999;211:791-798

    CrossRefPubMedWeb of Science
13. ↵
    Cha S, Lu S, Johnson G, Knopp EA. Dynamic susceptibility contrast MR imaging: correlation of signal intensity changes with cerebral blood volume measurements. J Magn Reson Imaging 2000;11:114-119

    CrossRefPubMed
14. ↵
    Poser CM, Paty DW, Scheinberg L, et al. New diagnostic criteria for multiple sclerosis: guidelines for research protocols. Ann Neurol 1983;13:227-231

    CrossRefPubMedWeb of Science
15. Rieth KG, Di Chiro G, Cromwell LD, et al. Primary demyelinating disease simulating glioma of the corpus callosum: report of three cases. J Neurosurg 1981;55:620-624

    PubMedWeb of Science
16. Kalyan-Raman UP, Garwacki DJ, Elwood PW. Demyelinating disease of corpus callosum presenting as glioma on magnetic resonance scan: a case documented with pathological findings. Neurosurgery 1987;21:247-250

    PubMedWeb of Science
17. ↵
    Dagher AP, Smirniotopoulos J. Tumefactive demyelinating lesions. Neuroradiology 1996;38:560-565

    CrossRefPubMedWeb of Science
18. ↵
    Charcot JM. Histologie de la sclerose en plaques. Gaz Hop 1868;41:554-566
19. ↵
    Lantos PL, Vandenberg SR, Kleihues P. Tumours of the nervous system. Greenfield's Neuropathology. ed 6. vol II. New York: Wiley; 1997:635
20. ↵
    Ginsberg LE, Fuller GN, Hashmi M, Leeds NE, Schomer DF. The significance of lack of MR contrast enhancement of supratentorial brain tumors in adults: histopathological evaluation of a series. Surg Neurol 1998;49:436-440

    CrossRefPubMedWeb of Science
21. Barker FG, Chang SM, Huhn SL, et al. Age and the risk of anaplasia in magnetic resonance-nonenhancing supratentorial cerebral tumors. Cancer 1997;80:936-941

    CrossRefPubMed
22. ↵
    Aronen HJ, Gazit IE, Louis DN, et al. Cerebral blood volume maps of gliomas: comparison with tumor grade and histologic findings. Radiology 1994;191:41-51

    PubMedWeb of Science
23. Cha S, Knopp EA, Johnson G, et al. Dynamic contrast-enhanced T2-weighted MR imaging of recurrent malignant gliomas treated with thalidomide and carboplatin. AJNR Am J Neuroradiol 2000;21:881-890

    Abstract/FREE Full Text
24. Adams C. Vascular aspects of multiple sclerosis. A Colour Atlas of Multiple Sclerosis & Other Myelin Disorders. London: Wolfe Medical Publications; 1989:184–187
25. Adams RD. A comparison of the morphology of the human demyelinating diseases and experimental “allergic” encephalomyelitis. In: Kies MW, Alvord EC, eds. “Allergic” Encephalomyelitis. Springfield: Charles C Thomas; 1959:183–209
26. ↵
    Tan IL, van Schijndel RA, Pouwels PJ, et al. MR venography of multiple sclerosis. AJNR Am J Neuroradiol 2000;21:1039-1042

    Abstract/FREE Full Text